Hodges Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96M Buy
8,424
+3,620
+75% +$1.29M 0.25% 103
2025
Q4
$1.57M Sell
4,804
-59
-1% -$18.7K 0.14% 131
2025
Q3
$1.37M Sell
4,863
-6,887
-59% -$2M 0.12% 133
2025
Q2
$3.28M Sell
11,750
-2,392
-17% -$678K 0.31% 89
2025
Q1
$4.41M Sell
14,142
-4,479
-24% -$1.32M 0.44% 71
2024
Q4
$4.85M Buy
18,621
+2,949
+19% +$875K 0.29% 97
2024
Q3
$5.05M Sell
15,672
-1,543
-9% -$505K 0.32% 89
2024
Q2
$5.38M Sell
17,215
-977
-5% -$287K 0.36% 88
2024
Q1
$5.17M Sell
18,192
-1,020
-5% -$298K 0.33% 91
2023
Q4
$5.53M Buy
19,212
+1,550
+9% +$422K 0.29% 96
2023
Q3
$4.75M Sell
17,662
-2,587
-13% -$646K 0.56% 51
2023
Q2
$4.74M Sell
20,249
-3,367
-14% -$781K 0.28% 98
2023
Q1
$4.81M Buy
23,616
+2,095
+10% +$514K 0.39% 74
2022
Q4
$9.26M Buy
+21,521
New +$5.77M 0.8% 37
2022
Q2
Sell
-876
Closed -$212K 213
2022
Q1
$212K Buy
+876
New +$201K 0.02% 232
2021
Q3
Sell
-871
Closed -$212K 234
2021
Q2
$212K Buy
+871
New +$214K 0.02% 230

Other funds holding AMGN

Hodges Capital Management's AMGN Position: Q1 2026 in Review

Hodges Capital Management increased its Amgen (AMGN) stake by 75% in Q1 2026, buying an estimated $1.29M and bringing the position to 8,424 shares worth $2.96M. The position accounts for 0.25% of the portfolio, ranked #103.

Hodges Capital Management first reported a position in AMGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $9.26M in Q4 2022. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hodges Capital Management held 8,424 shares of Amgen worth $2.96M as of Q1 2026.
  • Hodges Capital Management bought 3,620 Amgen shares in Q1 2026, an estimated $1.29M.
  • Amgen made up 0.25% of Hodges Capital Management's portfolio in Q1 2026, its #103 holding.
  • Hodges Capital Management first reported a position in Amgen in Q2 2021 and has held it in 16 quarters since.
  • Hodges Capital Management's Amgen position peaked at $9.26M in Q4 2022.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hodges Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.